Cargando…
Vector Transmission of Leishmania Abrogates Vaccine-Induced Protective Immunity
Numerous experimental vaccines have been developed to protect against the cutaneous and visceral forms of leishmaniasis caused by infection with the obligate intracellular protozoan Leishmania, but a human vaccine still does not exist. Remarkably, the efficacy of anti-Leishmania vaccines has never b...
Autores principales: | Peters, Nathan C., Kimblin, Nicola, Secundino, Nagila, Kamhawi, Shaden, Lawyer, Phillip, Sacks, David L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691580/ https://www.ncbi.nlm.nih.gov/pubmed/19543375 http://dx.doi.org/10.1371/journal.ppat.1000484 |
Ejemplares similares
-
Infection Parameters in the Sand Fly Vector That Predict Transmission of Leishmania major
por: Stamper, Lisa W., et al.
Publicado: (2011) -
Immunity to Distinct Sand Fly Salivary Proteins Primes the Anti-Leishmania Immune Response towards Protection or Exacerbation of Disease
por: Oliveira, Fabiano, et al.
Publicado: (2008) -
Leishmania major Survival in Selective Phlebotomus papatasi Sand Fly Vector Requires a Specific SCG-Encoded Lipophosphoglycan Galactosylation Pattern
por: Dobson, Deborah E., et al.
Publicado: (2010) -
Incrimination of Phlebotomus kandelakii and Phlebotomus balcanicus as Vectors of Leishmania infantum in Tbilisi, Georgia
por: Giorgobiani, Ekaterina, et al.
Publicado: (2012) -
Toward a Defined Anti-Leishmania Vaccine Targeting Vector Antigens: Characterization of a Protective Salivary Protein
por: Valenzuela, Jesus G., et al.
Publicado: (2001)